Need help finding what you are looking for?
Contact Us
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1298124
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1298124
Monoclonal Antibodies in Veterinary Health Market Share, Size, Trends, Industry Analysis Report, By Animal Type (Dogs, Others); By Application (Dermatology, Pain, Others); By End-Use; By Region; Segment Forecast, 2023 - 2032
PUBLISHED:
PAGES: 117 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global monoclonal antibodies in veterinary health market size is expected to reach USD 3,425.91 million by 2032, according to a new study by Polaris Market Research. The report "Monoclonal Antibodies in Veterinary Health Market Share, Size, Trends, Industry Analysis Report, By Animal Type (Dogs, Others); By Application (Dermatology, Pain, Others); By End-Use; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The market is being driven by factors such as the increasing prevalence of chronic diseases in companion animals, such as cancer and autoimmune disorders, which are being treated with mAb-based therapies due to their targeted approach and fewer side effects compared to traditional treatments. The rising pet adoption rate also creates a larger market for veterinary health products and services, including mAb treatments. This trend is expected to continue as more people adopt pets and seek high-quality healthcare services for their furry friends.
In addition to these factors, increasing research and development spending by industry players for the development of cancer treatments is anticipated to support market expansion over the forecast period. The increasing focus on zoonotic diseases, which can be transmitted between animals and humans, also drives a greater emphasis on animal health and disease prevention, potentially increasing demand for mAb-based treatments. Furthermore, developing novel mAb therapies and their approvals by regulatory authorities are expected to drive market growth as more effective treatments become available, expanding the range of applications for mAbs in veterinary health.
Monoclonal antibodies (mAbs) are increasingly used in veterinary medicine, particularly in treating cancer in companion animals such as dogs, cats, and horses. mAbs can target specific cancer cells, providing a potentially less toxic and more effective alternative to traditional chemotherapy. While the increasing availability of mAbs for veterinary use is a promising trend, regulatory challenges and high costs remain a concern for veterinarians and pet owners. Nonetheless, as more mAbs become available and competition increases, prices will likely decrease over time, making this advanced treatment more accessible to those with limited financial resources.
Monoclonal Antibodies in Veterinary Health Market Report Highlights
The dogs segment accounted for the highest revenue share in 2022 due to the growing number of pet dogs and their expensive healthcare, driven by the rising prevalence of chronic diseases and pet insurance adoption.
The dermatology segment held the largest revenue share of the market due to the rising incidence of dermatological diseases like fleas, ticks, and allergic dermatitis, with allergies, otitis externa, surface pyoderma, and seborrheic dermatitis being the most commonly diagnosed conditions.
The veterinary hospitals segment dominated the market in revenue share due to the increasing number of veterinary hospitals and veterinarians, generating significant revenue through innovative therapies.
North America dominated the global market in 2022 due to government and corporate sector initiatives, pet insurance's increasing popularity, and key market players' presence in the region.
The global key market players include: Adivo GmbH, Bayer Animal Health, Boehringer Ingelheim GmbH, Elanco; Indian Immunologicals Ltd., Invetx, Kindred Biosciences, Inc., Merck & Co. Inc, Nextmune, Virbac, Zoetis.
Polaris Market Research has segmented the Monoclonal Antibodies in Veterinary Health market report based on animal type, application, end-use, and region:
Monoclonal Antibodies in Veterinary Health, Animal Type Outlook (Revenue - USD Million, 2019 - 2032)
- Dogs
- Others
Monoclonal Antibodies in Veterinary Health, Application Outlook (Revenue - USD Million, 2019 - 2032)
- Dermatology
- Pain
- Others
Monoclonal Antibodies in Veterinary Health, End-Use Outlook (Revenue - USD Million, 2019 - 2032)
- Veterinary Hospitals
- Others
Monoclonal Antibodies in Veterinary Health, Regional Outlook (Revenue - USD Million, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Product Code: PM2580
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Monoclonal Antibodies in Veterinary Health Market Insights
- 4.1. Monoclonal Antibodies in Veterinary Health Market - End-Use Snapshot
- 4.2. Monoclonal Antibodies in Veterinary Health Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising pet owner concerns and expanding pet insurance
- 4.2.1.2. Rising importance of therapeutic monoclonal antibodies
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Increase in the cost of pet healthcare
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Monoclonal Antibodies in Veterinary Health Market End-Use Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Monoclonal Antibodies in Veterinary Health Market, by Animal Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- 5.3. Dogs
- 5.3.1. Global Monoclonal Antibodies in Veterinary Health Market, by Dogs, by Region, 2019-2032 (USD Million)
- 5.4. Others
- 5.4.1. Global Monoclonal Antibodies in Veterinary Health Market, by Others, by Region, 2019-2032 (USD Million)
6. Global Monoclonal Antibodies in Veterinary Health Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- 6.3. Dermatology
- 6.3.1. Global Monoclonal Antibodies in Veterinary Health Market, by Dermatology, by Region, 2019-2032 (USD Million)
- 6.4. Pain
- 6.4.1. Global Monoclonal Antibodies in Veterinary Health Market, by Pain, by Region, 2019-2032 (USD Million)
- 6.5. Others
- 6.5.1. Global Monoclonal Antibodies in Veterinary Health Market, by Others, by Region, 2019-2032 (USD Million)
7. Global Monoclonal Antibodies in Veterinary Health Market, by End-Use
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- 7.3. Veterinary Hospitals
- 7.3.1. Global Monoclonal Antibodies in Veterinary Health Market, by Veterinary Hospitals, By Region, 2019-2032 (USD Million)
- 7.4. Others
- 7.4.1. Global Monoclonal Antibodies in Veterinary Health Market, by Others, By Region, 2019-2032 (USD Million)
8. Global Monoclonal Antibodies in Veterinary Health Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Monoclonal Antibodies in Veterinary Health Market Assessment, By Geography, 2019-2032 (USD Million)
- 8.3. Monoclonal Antibodies in Veterinary Health Market - North America
- 8.3.1. North America: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- 8.3.2. North America: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- 8.3.3. North America: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- 8.3.4. Monoclonal Antibodies in Veterinary Health Market - U.S.
- 8.3.4.1. U.S.: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- 8.3.4.2. U.S.: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- 8.3.4.3. U.S.: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- 8.3.5. Monoclonal Antibodies in Veterinary Health Market - Canada
- 8.3.5.1. Canada: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- 8.3.5.2. Canada.: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- 8.3.5.3. Canada: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- 8.4. Monoclonal Antibodies in Veterinary Health Market - Europe
- 8.4.1. Europe: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- 8.4.2. Europe.: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- 8.4.3. Europe: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- 8.4.4. Monoclonal Antibodies in Veterinary Health Market - UK
- 8.4.4.1. UK: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- 8.4.4.2. UK.: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- 8.4.4.3. UK: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- 8.4.5. Monoclonal Antibodies in Veterinary Health Market - France
- 8.4.5.1. France: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- 8.4.5.2. France.: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- 8.4.5.3. France: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- 8.4.6. Monoclonal Antibodies in Veterinary Health Market - Germany
- 8.4.6.1. Germany: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- 8.4.6.2. Germany.: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- 8.4.6.3. Germany: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- 8.4.7. Monoclonal Antibodies in Veterinary Health Market - Italy
- 8.4.7.1. Italy: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- 8.4.7.2. Italy.: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- 8.4.7.3. Italy: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- 8.4.8. Monoclonal Antibodies in Veterinary Health Market - Spain
- 8.4.8.1. Spain: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- 8.4.8.2. Spain.: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- 8.4.8.3. Spain: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- 8.4.9. Monoclonal Antibodies in Veterinary Health Market - Netherlands
- 8.4.9.1. Netherlands: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- 8.4.9.2. Netherlands.: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- 8.4.9.3. Netherlands: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- 8.4.10. Monoclonal Antibodies in Veterinary Health Market - Russia
- 8.4.10.1. Russia: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- 8.4.10.2. Russia.: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- 8.4.10.3. Russia: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- 8.5. Monoclonal Antibodies in Veterinary Health Market - Asia Pacific
- 8.5.1. Asia Pacific: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- 8.5.2. Asia Pacific.: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- 8.5.3. Asia Pacific: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- 8.5.4. Monoclonal Antibodies in Veterinary Health Market - China
- 8.5.4.1. China: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- 8.5.4.2. China.: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- 8.5.4.3. China: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- 8.5.5. Monoclonal Antibodies in Veterinary Health Market - India
- 8.5.5.1. India: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- 8.5.5.2. India.: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- 8.5.5.3. India: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- 8.5.6. Monoclonal Antibodies in Veterinary Health Market - Malaysia
- 8.5.6.1. Malaysia: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- 8.5.6.2. Malaysia.: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- 8.5.6.3. Malaysia: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- 8.5.7. Monoclonal Antibodies in Veterinary Health Market - Japan
- 8.5.7.1. Japan: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- 8.5.7.2. Japan.: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- 8.5.7.3. Japan: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- 8.5.8. Monoclonal Antibodies in Veterinary Health Market - Indonesia
- 8.5.8.1. Indonesia: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- 8.5.8.2. Indonesia.: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- 8.5.8.3. Indonesia: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- 8.5.9. Monoclonal Antibodies in Veterinary Health Market - South Korea
- 8.5.9.1. South Korea: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- 8.5.9.2. South Korea.: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- 8.5.9.3. South Korea: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- 8.6. Monoclonal Antibodies in Veterinary Health Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- 8.6.2. Middle East & Africa.: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- 8.6.3. Middle East & Africa: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- 8.6.4. Monoclonal Antibodies in Veterinary Health Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- 8.6.4.2. Saudi Arabia.: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- 8.6.4.3. Saudi Arabia: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- 8.6.5. Monoclonal Antibodies in Veterinary Health Market - UAE
- 8.6.5.1. UAE: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- 8.6.5.2. UAE.: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- 8.6.5.3. UAE: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- 8.6.6. Monoclonal Antibodies in Veterinary Health Market - Israel
- 8.6.6.1. Israel: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- 8.6.6.2. Israel.: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- 8.6.6.3. Israel: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- 8.6.7. Monoclonal Antibodies in Veterinary Health Market - South Africa
- 8.6.7.1. South Africa: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- 8.6.7.2. South Africa.: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- 8.6.7.3. South Africa: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- 8.7. Monoclonal Antibodies in Veterinary Health Market - Latin America
- 8.7.1. Latin America: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- 8.7.2. Latin America.: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- 8.7.3. Latin America: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- 8.7.4. Monoclonal Antibodies in Veterinary Health Market - Mexico
- 8.7.4.1. Mexico: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- 8.7.4.2. Mexico.: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- 8.7.4.3. Mexico: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- 8.7.5. Monoclonal Antibodies in Veterinary Health Market - Brazil
- 8.7.5.1. Brazil: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- 8.7.5.2. Brazil.: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- 8.7.5.3. Brazil: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- 8.7.6. Monoclonal Antibodies in Veterinary Health Market - Argentina
- 8.7.6.1. Argentina: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- 8.7.6.2. Argentina.: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- 8.7.6.3. Argentina: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. adivo GmbH
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Bayer Animal Health
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Boehringer Ingelheim GmbH
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Elanco
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Indian Immunologicals Ltd
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Invetx
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Kindred Biosciences, Inc
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Merck & Co. Inc
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Nextmune
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Virbac
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Zoetis
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
Product Code: PM2580
List of Tables
- Table 1 Global Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- Table 2 Global Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- Table 3 Global Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- Table 4 Monoclonal Antibodies in Veterinary Health Market Assessment, By Geography, 2019-2032 (USD Million)
- Table 5 North America: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- Table 6 North America: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- Table 7 North America: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- Table 8 U.S.: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- Table 9 U.S.: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- Table 10 U.S.: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- Table 11 Canada: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- Table 12 Canada: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- Table 13 Canada: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- Table 14 Europe: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- Table 15 Europe: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- Table 16 Europe: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- Table 17 UK: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- Table 18 UK: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- Table 19 UK: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- Table 20 France: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- Table 21 France: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- Table 22 France: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- Table 23 Germany: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- Table 24 Germany: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- Table 25 Germany: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- Table 26 Italy: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- Table 27 Italy: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- Table 28 Italy: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- Table 29 Spain: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- Table 30 Spain: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- Table 31 Spain: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- Table 32 Netherlands: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- Table 33 Netherlands: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- Table 34 Netherlands: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- Table 35 Russia: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- Table 36 Russia: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- Table 37 Russia: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- Table 38 Asia Pacific: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- Table 39 Asia Pacific: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- Table 40 Asia Pacific: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- Table 41 China: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- Table 42 China: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- Table 43 China: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- Table 44 India: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- Table 45 India: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- Table 46 India: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- Table 47 Malaysia: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- Table 48 Malaysia: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- Table 49 Malaysia: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- Table 50 Japan: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- Table 51 Japan: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- Table 52 Japan: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- Table 53 Indonesia: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- Table 54 Indonesia: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- Table 55 Indonesia: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- Table 56 South Korea: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- Table 57 South Korea: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- Table 58 South Korea: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- Table 59 Middle East & Africa: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- Table 60 Middle East & Africa: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- Table 61 Middle East & Africa: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- Table 62 Saudi Arabia: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- Table 63 Saudi Arabia: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- Table 64 Saudi Arabia: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- Table 65 UAE: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- Table 66 UAE: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- Table 67 UAE: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- Table 68 Israel: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- Table 69 Israel: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- Table 70 Israel: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- Table 71 South Africa: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- Table 72 South Africa: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- Table 73 South Africa: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- Table 74 Latin America: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- Table 75 Latin America: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- Table 76 Latin America: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- Table 77 Mexico: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- Table 78 Mexico: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- Table 79 Mexico: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- Table 80 Brazil: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- Table 81 Brazil: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- Table 82 Brazil: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
- Table 83 Argentina: Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2019-2032 (USD Million)
- Table 84 Argentina: Monoclonal Antibodies in Veterinary Health Market, by Application, 2019-2032 (USD Million)
- Table 85 Argentina: Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2019-2032 (USD Million)
List of Figures
- Figure 1. Global Monoclonal Antibodies in Veterinary Health Market, 2019-2032 (USD Million)
- Figure 2. Integrated Ecosystem
- Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
- Figure 4. Market by Geography
- Figure 5. Porter's Five Forces
- Figure 6. Market by Application
- Figure 7. Global Monoclonal Antibodies in Veterinary Health Market, by Application, 2022 & 2032 (USD Million)
- Figure 8. Market by Animal Type
- Figure 9. Global Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2022 & 2032 (USD Million)
- Figure 10. Market by End-Use
- Figure 11. Global Monoclonal Antibodies in Veterinary Health Market, by End-Use, 2022 & 2032 (USD Million)
- Figure 12. Monoclonal Antibodies in Veterinary Health Market Assessment, By Geography, 2019-2032 (USD Million)
- Figure 13. Strategic Analysis - Monoclonal Antibodies in Veterinary Health Market
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.